Tanaka T, Ohmura T, Hidaka H
Pharmacology. 1983;26(5):249-57. doi: 10.1159/000137808.
Troponin I inhibited, concentration-dependently, [3H]-N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) and [3H]-trifluoperazine (TFP) binding to purified bovine brain calmodulin (CaM). Selective oxidation of methionine residues of CaM by N-chlorosuccinimide resulted in a rapid decrease in [3H]-W-7, [3H]-TFP and [14C]-chlorpromazine binding concomitant with the loss of CaM activity. Carbethoxylation of histidine residues, nitration of tyrosine residues and chemical modification of arginine residues with 1,2-cyclohexanedione produced no significant changes either in [3H]-W-7 binding to CaM or in the ability of CaM to stimulate phosphodiesterase. Our results suggest that the binding sites of these CaM antagonists on CaM may be located between the second and third Ca2+-binding loops.
肌钙蛋白I浓度依赖性地抑制[3H]-N-(6-氨基己基)-5-氯-1-萘磺酰胺(W-7)和[3H]-三氟拉嗪(TFP)与纯化的牛脑钙调蛋白(CaM)的结合。N-氯代琥珀酰亚胺对CaM蛋氨酸残基的选择性氧化导致[3H]-W-7、[3H]-TFP和[14C]-氯丙嗪结合迅速减少,同时CaM活性丧失。组氨酸残基的乙氧羰基化、酪氨酸残基的硝化以及用1,2-环己二酮对精氨酸残基的化学修饰,在[3H]-W-7与CaM的结合或CaM刺激磷酸二酯酶的能力方面均未产生显著变化。我们的结果表明,这些CaM拮抗剂在CaM上的结合位点可能位于第二个和第三个Ca2+结合环之间。